Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone Regeneration | 23 | 2015 | 68 | 4.130 |
Why?
|
Bone and Bones | 24 | 2018 | 119 | 4.090 |
Why?
|
Prostheses and Implants | 25 | 2017 | 166 | 3.860 |
Why?
|
Femur | 47 | 2016 | 396 | 3.540 |
Why?
|
Bone Remodeling | 18 | 2019 | 44 | 3.200 |
Why?
|
Animals | 112 | 2020 | 4577 | 3.130 |
Why?
|
Bone Density | 31 | 2018 | 134 | 3.130 |
Why?
|
Osteogenesis | 22 | 2020 | 96 | 3.030 |
Why?
|
X-Ray Microtomography | 16 | 2018 | 72 | 2.870 |
Why?
|
Transforming Growth Factor beta | 16 | 2014 | 123 | 2.700 |
Why?
|
Bone Matrix | 6 | 2017 | 28 | 2.570 |
Why?
|
Osseointegration | 17 | 2019 | 76 | 2.430 |
Why?
|
Osteolysis | 7 | 2019 | 149 | 2.260 |
Why?
|
Rats | 41 | 2019 | 857 | 2.170 |
Why?
|
Rats, Sprague-Dawley | 31 | 2019 | 452 | 1.980 |
Why?
|
Osteoporosis | 6 | 2020 | 80 | 1.890 |
Why?
|
Implants, Experimental | 5 | 2019 | 29 | 1.870 |
Why?
|
Bone Morphogenetic Proteins | 7 | 2015 | 102 | 1.760 |
Why?
|
Biomarkers | 8 | 2019 | 690 | 1.680 |
Why?
|
Titanium | 24 | 2017 | 209 | 1.540 |
Why?
|
Hip Prosthesis | 29 | 2014 | 605 | 1.530 |
Why?
|
Cartilage, Articular | 13 | 2017 | 524 | 1.380 |
Why?
|
Calcium, Dietary | 2 | 2018 | 12 | 1.280 |
Why?
|
Prosthesis Failure | 11 | 2020 | 556 | 1.280 |
Why?
|
Male | 89 | 2019 | 15628 | 1.180 |
Why?
|
Dogs | 40 | 2007 | 255 | 1.080 |
Why?
|
Models, Animal | 16 | 2015 | 126 | 1.080 |
Why?
|
Antibodies | 3 | 2015 | 64 | 1.070 |
Why?
|
Disease Models, Animal | 14 | 2017 | 730 | 1.070 |
Why?
|
Calcification, Physiologic | 6 | 2019 | 20 | 1.050 |
Why?
|
Glycoproteins | 2 | 2015 | 58 | 1.030 |
Why?
|
Fracture Healing | 5 | 2014 | 40 | 1.010 |
Why?
|
Tibia | 16 | 2014 | 259 | 0.990 |
Why?
|
Bone Development | 9 | 2020 | 32 | 0.970 |
Why?
|
Arthroplasty, Replacement, Hip | 7 | 2018 | 863 | 0.970 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2018 | 59 | 0.900 |
Why?
|
Biomechanical Phenomena | 20 | 2020 | 668 | 0.880 |
Why?
|
Gene Expression Regulation | 3 | 2014 | 287 | 0.880 |
Why?
|
Bone Resorption | 11 | 2015 | 104 | 0.870 |
Why?
|
Osteocalcin | 3 | 2019 | 19 | 0.830 |
Why?
|
Humerus | 9 | 2014 | 98 | 0.810 |
Why?
|
Biocompatible Materials | 9 | 2007 | 114 | 0.810 |
Why?
|
Bone Marrow Cells | 7 | 2015 | 57 | 0.800 |
Why?
|
Body Weight | 4 | 2019 | 133 | 0.800 |
Why?
|
Lactation | 2 | 2018 | 62 | 0.780 |
Why?
|
Bone Morphogenetic Protein 2 | 9 | 2015 | 46 | 0.760 |
Why?
|
Bone Marrow | 6 | 2015 | 73 | 0.740 |
Why?
|
Prosthesis Implantation | 4 | 2012 | 33 | 0.730 |
Why?
|
Arthroplasty, Replacement | 3 | 2020 | 147 | 0.720 |
Why?
|
Stromal Cells | 5 | 2015 | 35 | 0.720 |
Why?
|
Aging | 6 | 2018 | 1599 | 0.710 |
Why?
|
Microscopy, Electron, Scanning | 15 | 2017 | 86 | 0.710 |
Why?
|
Minerals | 3 | 2018 | 6 | 0.700 |
Why?
|
Joint Prosthesis | 3 | 2020 | 83 | 0.690 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 8 | 0.680 |
Why?
|
Weaning | 1 | 2018 | 5 | 0.680 |
Why?
|
Female | 44 | 2018 | 16202 | 0.680 |
Why?
|
Contrast Media | 2 | 2017 | 125 | 0.680 |
Why?
|
Parathyroid Hormone | 2 | 2015 | 23 | 0.670 |
Why?
|
Joints | 4 | 2014 | 97 | 0.650 |
Why?
|
Materials Testing | 8 | 2012 | 137 | 0.650 |
Why?
|
Wnt Signaling Pathway | 1 | 2018 | 30 | 0.650 |
Why?
|
Adipose Tissue | 1 | 2018 | 73 | 0.640 |
Why?
|
Calcium Phosphates | 5 | 2005 | 25 | 0.630 |
Why?
|
Stress, Mechanical | 18 | 2014 | 166 | 0.620 |
Why?
|
Mice | 10 | 2020 | 1609 | 0.610 |
Why?
|
Cortical Bone | 1 | 2017 | 7 | 0.610 |
Why?
|
Kidney | 1 | 2018 | 173 | 0.600 |
Why?
|
Coated Materials, Biocompatible | 3 | 2007 | 41 | 0.590 |
Why?
|
Tissue Engineering | 3 | 2007 | 37 | 0.580 |
Why?
|
Polyethylene | 2 | 2019 | 116 | 0.580 |
Why?
|
Genetic Markers | 2 | 2015 | 58 | 0.580 |
Why?
|
Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2016 | 2 | 0.580 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 220 | 0.580 |
Why?
|
Mice, Inbred C57BL | 5 | 2017 | 441 | 0.570 |
Why?
|
Recombinant Proteins | 14 | 2014 | 251 | 0.540 |
Why?
|
Radiography | 18 | 2018 | 678 | 0.530 |
Why?
|
Humans | 70 | 2020 | 29330 | 0.530 |
Why?
|
Gene Expression Profiling | 5 | 2010 | 151 | 0.520 |
Why?
|
Tomography, X-Ray Computed | 13 | 2012 | 770 | 0.520 |
Why?
|
Extracellular Matrix Proteins | 3 | 2011 | 127 | 0.510 |
Why?
|
Mutation | 1 | 2016 | 383 | 0.500 |
Why?
|
Hip Joint | 10 | 2004 | 367 | 0.500 |
Why?
|
Osteoarthritis, Knee | 6 | 2010 | 381 | 0.490 |
Why?
|
Adaptation, Physiological | 6 | 2014 | 55 | 0.490 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 90 | 0.490 |
Why?
|
Osteoarthritis | 11 | 2004 | 363 | 0.480 |
Why?
|
Heterocyclic Compounds | 2 | 2012 | 11 | 0.470 |
Why?
|
Cell Movement | 3 | 2012 | 104 | 0.470 |
Why?
|
Gene Expression | 5 | 2013 | 226 | 0.460 |
Why?
|
Prosthesis Design | 19 | 2014 | 502 | 0.460 |
Why?
|
Adult Stem Cells | 1 | 2012 | 2 | 0.450 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2012 | 5 | 0.450 |
Why?
|
Acetabulum | 7 | 2005 | 208 | 0.440 |
Why?
|
Gait | 10 | 2014 | 404 | 0.440 |
Why?
|
Running | 1 | 2012 | 10 | 0.440 |
Why?
|
Metals | 3 | 2011 | 160 | 0.430 |
Why?
|
Electron Microscope Tomography | 1 | 2011 | 2 | 0.420 |
Why?
|
Osteoblasts | 5 | 2015 | 63 | 0.410 |
Why?
|
Ultrasonic Therapy | 4 | 2014 | 20 | 0.410 |
Why?
|
Mechanical Phenomena | 1 | 2011 | 22 | 0.410 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 258 | 0.400 |
Why?
|
Polymers | 3 | 2007 | 42 | 0.400 |
Why?
|
Weight-Bearing | 8 | 2010 | 164 | 0.390 |
Why?
|
Knee Prosthesis | 7 | 2014 | 248 | 0.390 |
Why?
|
Porosity | 8 | 2018 | 71 | 0.380 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2014 | 438 | 0.370 |
Why?
|
Cell Differentiation | 4 | 2020 | 147 | 0.360 |
Why?
|
Surface Properties | 8 | 2019 | 144 | 0.360 |
Why?
|
Cognitive Dysfunction | 1 | 2018 | 938 | 0.360 |
Why?
|
Knee Joint | 8 | 2014 | 797 | 0.350 |
Why?
|
Durapatite | 3 | 2005 | 11 | 0.350 |
Why?
|
Middle Aged | 33 | 2018 | 9816 | 0.340 |
Why?
|
Aged | 25 | 2018 | 9441 | 0.340 |
Why?
|
Models, Biological | 9 | 2014 | 343 | 0.340 |
Why?
|
Ultrasonics | 2 | 2005 | 15 | 0.330 |
Why?
|
Diphosphonates | 2 | 2014 | 17 | 0.330 |
Why?
|
Transforming Growth Factor beta2 | 5 | 2006 | 14 | 0.330 |
Why?
|
Biomimetic Materials | 2 | 2006 | 8 | 0.330 |
Why?
|
Regeneration | 3 | 2015 | 27 | 0.320 |
Why?
|
Osteocytes | 3 | 2014 | 15 | 0.320 |
Why?
|
Time Factors | 15 | 2012 | 1614 | 0.320 |
Why?
|
Polyethyleneimine | 3 | 2015 | 6 | 0.300 |
Why?
|
Bone Nails | 4 | 2006 | 17 | 0.300 |
Why?
|
Alzheimer Disease | 1 | 2018 | 1942 | 0.300 |
Why?
|
Bone Cements | 9 | 1996 | 99 | 0.290 |
Why?
|
Osteogenesis, Distraction | 4 | 2007 | 12 | 0.290 |
Why?
|
Mandible | 4 | 2007 | 15 | 0.290 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 2 | 2016 | 11 | 0.280 |
Why?
|
Tissue Scaffolds | 3 | 2015 | 22 | 0.280 |
Why?
|
Ioxaglic Acid | 2 | 2017 | 5 | 0.270 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 521 | 0.260 |
Why?
|
Mice, Transgenic | 3 | 2016 | 251 | 0.260 |
Why?
|
Sodium Chloride | 1 | 2005 | 37 | 0.260 |
Why?
|
Anabolic Agents | 1 | 2004 | 6 | 0.260 |
Why?
|
Range of Motion, Articular | 3 | 2006 | 699 | 0.260 |
Why?
|
Absorptiometry, Photon | 8 | 2006 | 76 | 0.260 |
Why?
|
Bone Screws | 4 | 1994 | 181 | 0.260 |
Why?
|
Skull | 2 | 2015 | 25 | 0.260 |
Why?
|
Bone Transplantation | 5 | 2004 | 224 | 0.260 |
Why?
|
Collagen | 5 | 2016 | 103 | 0.250 |
Why?
|
Adult | 26 | 2010 | 8592 | 0.250 |
Why?
|
Cell Culture Techniques | 1 | 2004 | 44 | 0.250 |
Why?
|
Phenotype | 2 | 2016 | 353 | 0.250 |
Why?
|
Graft Survival | 1 | 2004 | 97 | 0.250 |
Why?
|
Ovariectomy | 2 | 2015 | 27 | 0.240 |
Why?
|
Calcium | 2 | 2018 | 498 | 0.240 |
Why?
|
Signal Transduction | 4 | 2020 | 486 | 0.230 |
Why?
|
Joint Diseases | 1 | 2004 | 110 | 0.230 |
Why?
|
Regression Analysis | 4 | 2016 | 297 | 0.230 |
Why?
|
Hip | 4 | 2000 | 40 | 0.220 |
Why?
|
Risk Assessment | 2 | 2018 | 679 | 0.220 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 4 | 2009 | 27 | 0.220 |
Why?
|
Cells, Cultured | 8 | 2011 | 686 | 0.220 |
Why?
|
Alloys | 7 | 2004 | 102 | 0.220 |
Why?
|
Random Allocation | 2 | 2012 | 146 | 0.220 |
Why?
|
Aged, 80 and over | 12 | 2018 | 4844 | 0.220 |
Why?
|
Receptors, CXCR4 | 2 | 2012 | 27 | 0.220 |
Why?
|
Talus | 1 | 2002 | 10 | 0.210 |
Why?
|
Photogrammetry | 1 | 2001 | 2 | 0.210 |
Why?
|
Imidazoles | 1 | 2002 | 72 | 0.200 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2015 | 65 | 0.200 |
Why?
|
Chondrogenesis | 2 | 2015 | 27 | 0.200 |
Why?
|
Tissue and Organ Harvesting | 1 | 2001 | 17 | 0.200 |
Why?
|
Metatarsus | 1 | 2000 | 1 | 0.200 |
Why?
|
Prosthesis Retention | 1 | 2020 | 3 | 0.200 |
Why?
|
Bone-Implant Interface | 1 | 2020 | 6 | 0.200 |
Why?
|
Plasmids | 3 | 2015 | 44 | 0.190 |
Why?
|
Cartilage Diseases | 1 | 2002 | 83 | 0.190 |
Why?
|
Fracture Fixation | 2 | 2014 | 24 | 0.190 |
Why?
|
Wound Healing | 3 | 2015 | 168 | 0.190 |
Why?
|
Mice, Knockout | 3 | 2020 | 303 | 0.190 |
Why?
|
Vitallium | 2 | 2011 | 25 | 0.190 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 35 | 0.180 |
Why?
|
Pilot Projects | 5 | 2015 | 393 | 0.180 |
Why?
|
Computer Simulation | 4 | 2000 | 218 | 0.180 |
Why?
|
Hindlimb | 3 | 2012 | 23 | 0.180 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 127 | 0.180 |
Why?
|
NF-kappa B | 1 | 2020 | 107 | 0.180 |
Why?
|
Movement | 5 | 2006 | 143 | 0.180 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 215 | 0.170 |
Why?
|
Femur Neck | 1 | 1999 | 18 | 0.170 |
Why?
|
Osteoarthritis, Hip | 2 | 2001 | 94 | 0.170 |
Why?
|
Cobalt | 2 | 2014 | 116 | 0.170 |
Why?
|
Lumbar Vertebrae | 4 | 2014 | 487 | 0.170 |
Why?
|
Phosphates | 1 | 2018 | 20 | 0.170 |
Why?
|
X-Rays | 2 | 2016 | 5 | 0.170 |
Why?
|
Synchrotrons | 2 | 2009 | 2 | 0.160 |
Why?
|
Treatment Outcome | 6 | 2014 | 3475 | 0.160 |
Why?
|
Mice, Inbred BALB C | 2 | 2015 | 262 | 0.160 |
Why?
|
Memory, Short-Term | 1 | 2018 | 102 | 0.160 |
Why?
|
Trypsin | 1 | 2017 | 6 | 0.160 |
Why?
|
Microscopy, Fluorescence | 2 | 2014 | 84 | 0.160 |
Why?
|
Academic Medical Centers | 1 | 2018 | 142 | 0.160 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 30 | 0.150 |
Why?
|
Double-Blind Method | 1 | 2018 | 503 | 0.150 |
Why?
|
Severity of Illness Index | 2 | 2018 | 1110 | 0.150 |
Why?
|
Pregnancy | 1 | 2018 | 403 | 0.150 |
Why?
|
Gene Transfer Techniques | 2 | 2015 | 34 | 0.150 |
Why?
|
Cell Proliferation | 3 | 2013 | 201 | 0.150 |
Why?
|
Prevalence | 1 | 2018 | 486 | 0.150 |
Why?
|
Tensile Strength | 2 | 2012 | 29 | 0.150 |
Why?
|
Comorbidity | 1 | 2018 | 497 | 0.150 |
Why?
|
Motor Activity | 1 | 2019 | 369 | 0.150 |
Why?
|
Rabbits | 6 | 2015 | 299 | 0.140 |
Why?
|
Mandibular Condyle | 2 | 2006 | 4 | 0.140 |
Why?
|
Point Mutation | 1 | 2016 | 30 | 0.140 |
Why?
|
Temporal Bone | 2 | 2006 | 10 | 0.140 |
Why?
|
Femoral Fractures | 2 | 2006 | 41 | 0.140 |
Why?
|
Benzylamines | 2 | 2012 | 12 | 0.140 |
Why?
|
Prognosis | 1 | 2018 | 839 | 0.140 |
Why?
|
Independent Living | 1 | 2018 | 281 | 0.140 |
Why?
|
RNA | 1 | 2015 | 39 | 0.140 |
Why?
|
Periosteum | 2 | 2012 | 6 | 0.140 |
Why?
|
Wnt Proteins | 2 | 2012 | 16 | 0.140 |
Why?
|
DNA Primers | 2 | 2005 | 51 | 0.140 |
Why?
|
Mice, Inbred Strains | 1 | 2015 | 28 | 0.130 |
Why?
|
Mice, Inbred C3H | 1 | 2015 | 33 | 0.130 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 75 | 0.130 |
Why?
|
Species Specificity | 1 | 2015 | 70 | 0.130 |
Why?
|
Arthroplasty, Subchondral | 1 | 2015 | 27 | 0.130 |
Why?
|
Growth Substances | 2 | 2005 | 41 | 0.130 |
Why?
|
Proteoglycans | 4 | 2008 | 337 | 0.130 |
Why?
|
Genotype | 1 | 2016 | 405 | 0.130 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2006 | 220 | 0.130 |
Why?
|
Copper | 1 | 2014 | 9 | 0.130 |
Why?
|
Chitosan | 1 | 2014 | 4 | 0.130 |
Why?
|
Down-Regulation | 2 | 2005 | 115 | 0.130 |
Why?
|
Nickel | 1 | 2014 | 29 | 0.130 |
Why?
|
Diaphyses | 1 | 2014 | 4 | 0.130 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2015 | 39 | 0.130 |
Why?
|
Receptors, Dopamine D2 | 1 | 2014 | 18 | 0.130 |
Why?
|
Microvessels | 1 | 2014 | 16 | 0.130 |
Why?
|
Cementation | 6 | 1997 | 36 | 0.130 |
Why?
|
Macaca fascicularis | 1 | 2014 | 26 | 0.130 |
Why?
|
Organ Specificity | 1 | 2014 | 46 | 0.130 |
Why?
|
RNA, Messenger | 2 | 2005 | 326 | 0.120 |
Why?
|
Corrosion | 1 | 2014 | 139 | 0.120 |
Why?
|
Calcitonin | 1 | 2014 | 15 | 0.120 |
Why?
|
Etidronic Acid | 2 | 2004 | 2 | 0.120 |
Why?
|
Bone Density Conservation Agents | 1 | 2014 | 14 | 0.120 |
Why?
|
Alendronate | 2 | 2004 | 8 | 0.120 |
Why?
|
Spinal Fusion | 3 | 1995 | 516 | 0.120 |
Why?
|
Osteoporotic Fractures | 1 | 2014 | 12 | 0.120 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2013 | 4 | 0.120 |
Why?
|
Shoulder | 1 | 2015 | 154 | 0.120 |
Why?
|
Corpus Striatum | 1 | 2014 | 111 | 0.120 |
Why?
|
Methamphetamine | 1 | 2014 | 48 | 0.120 |
Why?
|
Spinal Diseases | 1 | 1995 | 150 | 0.120 |
Why?
|
Polyethylenes | 4 | 1998 | 50 | 0.120 |
Why?
|
Reference Values | 2 | 2012 | 227 | 0.120 |
Why?
|
Ossification, Heterotopic | 4 | 2009 | 42 | 0.110 |
Why?
|
Colony-Forming Units Assay | 1 | 2012 | 4 | 0.110 |
Why?
|
Hematopoietic Stem Cells | 1 | 2012 | 13 | 0.110 |
Why?
|
Reproducibility of Results | 2 | 2014 | 788 | 0.110 |
Why?
|
Flow Cytometry | 1 | 2012 | 197 | 0.110 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 223 | 0.110 |
Why?
|
Endothelial Cells | 1 | 2012 | 63 | 0.110 |
Why?
|
Chemokine CXCL12 | 1 | 2012 | 7 | 0.110 |
Why?
|
Walking | 5 | 2014 | 252 | 0.110 |
Why?
|
Matrix Metalloproteinases | 2 | 2010 | 22 | 0.100 |
Why?
|
Calcineurin | 1 | 2011 | 8 | 0.100 |
Why?
|
NFATC Transcription Factors | 1 | 2011 | 15 | 0.100 |
Why?
|
Metatarsal Bones | 2 | 2003 | 6 | 0.100 |
Why?
|
Cell Communication | 1 | 2011 | 32 | 0.100 |
Why?
|
Gap Junctions | 1 | 2011 | 23 | 0.100 |
Why?
|
Rats, Inbred F344 | 3 | 2015 | 48 | 0.100 |
Why?
|
Matrix Metalloproteinase 13 | 2 | 2007 | 30 | 0.100 |
Why?
|
Nociceptors | 1 | 2010 | 19 | 0.100 |
Why?
|
DNA | 3 | 2015 | 125 | 0.100 |
Why?
|
Fractures, Bone | 2 | 2014 | 73 | 0.090 |
Why?
|
Quadriceps Muscle | 1 | 2010 | 27 | 0.090 |
Why?
|
Ganglia, Spinal | 1 | 2010 | 57 | 0.090 |
Why?
|
Elasticity | 5 | 2001 | 39 | 0.090 |
Why?
|
Knee | 1 | 2010 | 44 | 0.090 |
Why?
|
Equipment Design | 4 | 2010 | 184 | 0.090 |
Why?
|
Spinal Cord | 1 | 2010 | 103 | 0.090 |
Why?
|
Fracture Fixation, Internal | 1 | 1990 | 71 | 0.090 |
Why?
|
Risk Factors | 2 | 2014 | 2435 | 0.090 |
Why?
|
Scattering, Radiation | 2 | 2009 | 39 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2010 | 57 | 0.090 |
Why?
|
Pan troglodytes | 1 | 1989 | 22 | 0.090 |
Why?
|
Exercise Therapy | 1 | 2010 | 112 | 0.090 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2008 | 31 | 0.090 |
Why?
|
Arthralgia | 1 | 2010 | 121 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 145 | 0.080 |
Why?
|
Hemarthrosis | 1 | 2008 | 15 | 0.080 |
Why?
|
Craniosynostoses | 1 | 2007 | 2 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2007 | 32 | 0.080 |
Why?
|
Equipment Failure Analysis | 2 | 2006 | 106 | 0.080 |
Why?
|
Hemophilia A | 1 | 2008 | 41 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 37 | 0.080 |
Why?
|
Cartilage | 3 | 2004 | 148 | 0.080 |
Why?
|
Cell Lineage | 1 | 2007 | 29 | 0.080 |
Why?
|
Up-Regulation | 2 | 2007 | 177 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2007 | 40 | 0.080 |
Why?
|
Acrylic Resins | 1 | 2007 | 2 | 0.080 |
Why?
|
Chromium Alloys | 2 | 2005 | 48 | 0.080 |
Why?
|
Cell Line | 3 | 2014 | 299 | 0.080 |
Why?
|
Adolescent | 4 | 2002 | 2274 | 0.080 |
Why?
|
Hydroxyapatites | 2 | 2005 | 9 | 0.080 |
Why?
|
Guided Tissue Regeneration | 1 | 2006 | 11 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 4 | 2015 | 222 | 0.070 |
Why?
|
Temporomandibular Joint | 1 | 2007 | 13 | 0.070 |
Why?
|
Inflammation | 1 | 2009 | 343 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2006 | 74 | 0.070 |
Why?
|
X-Ray Diffraction | 1 | 2006 | 3 | 0.070 |
Why?
|
Models, Anatomic | 1 | 2006 | 52 | 0.070 |
Why?
|
Drug Synergism | 1 | 2006 | 63 | 0.070 |
Why?
|
Radiographic Image Enhancement | 2 | 2004 | 16 | 0.070 |
Why?
|
Posture | 1 | 2006 | 78 | 0.070 |
Why?
|
Locomotion | 1 | 2005 | 24 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2005 | 26 | 0.070 |
Why?
|
Exercise Test | 1 | 2006 | 122 | 0.070 |
Why?
|
In Situ Hybridization | 1 | 2005 | 46 | 0.070 |
Why?
|
Chymopapain | 2 | 2003 | 5 | 0.070 |
Why?
|
Shear Strength | 1 | 2005 | 7 | 0.070 |
Why?
|
Delayed-Action Preparations | 1 | 2005 | 38 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 241 | 0.070 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2014 | 696 | 0.070 |
Why?
|
In Vitro Techniques | 3 | 2006 | 214 | 0.070 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2005 | 62 | 0.070 |
Why?
|
Reoperation | 6 | 1996 | 932 | 0.070 |
Why?
|
Evaluation Studies as Topic | 2 | 1997 | 56 | 0.070 |
Why?
|
Bone Marrow Purging | 1 | 2004 | 3 | 0.070 |
Why?
|
Base Sequence | 1 | 2005 | 134 | 0.070 |
Why?
|
Tissue Transplantation | 1 | 2004 | 19 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 161 | 0.060 |
Why?
|
Temperature | 1 | 2004 | 76 | 0.060 |
Why?
|
Jogging | 1 | 2004 | 3 | 0.060 |
Why?
|
Cell Survival | 2 | 2015 | 169 | 0.060 |
Why?
|
Orthopedic Fixation Devices | 2 | 2014 | 24 | 0.060 |
Why?
|
Arthrography | 2 | 2006 | 26 | 0.060 |
Why?
|
Genetic Therapy | 2 | 2015 | 87 | 0.060 |
Why?
|
Body Mass Index | 1 | 2006 | 426 | 0.060 |
Why?
|
Alkaline Phosphatase | 2 | 2015 | 16 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2005 | 1828 | 0.060 |
Why?
|
Orthopedics | 1 | 2005 | 127 | 0.060 |
Why?
|
Growth Plate | 1 | 2003 | 23 | 0.060 |
Why?
|
Protective Agents | 1 | 2003 | 9 | 0.060 |
Why?
|
Anthropometry | 1 | 2003 | 37 | 0.060 |
Why?
|
Ankle Joint | 1 | 2003 | 39 | 0.060 |
Why?
|
Algorithms | 2 | 2014 | 400 | 0.060 |
Why?
|
Amino Acids | 1 | 2002 | 20 | 0.050 |
Why?
|
Hyaluronic Acid | 1 | 2003 | 94 | 0.050 |
Why?
|
Prospective Studies | 3 | 2003 | 1809 | 0.050 |
Why?
|
Transplantation, Autologous | 3 | 2007 | 195 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 363 | 0.050 |
Why?
|
Radiation Dosage | 2 | 2011 | 31 | 0.050 |
Why?
|
Surgical Instruments | 1 | 2001 | 25 | 0.050 |
Why?
|
Radius | 1 | 2001 | 32 | 0.050 |
Why?
|
Ilium | 1 | 2001 | 31 | 0.050 |
Why?
|
Wrist Joint | 1 | 2001 | 61 | 0.050 |
Why?
|
Finite Element Analysis | 1 | 2000 | 44 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2002 | 636 | 0.050 |
Why?
|
Osteoclasts | 1 | 2020 | 19 | 0.050 |
Why?
|
Infant | 2 | 1996 | 531 | 0.050 |
Why?
|
Analysis of Variance | 4 | 2007 | 320 | 0.040 |
Why?
|
Child, Preschool | 2 | 1996 | 641 | 0.040 |
Why?
|
Infant, Newborn | 2 | 1996 | 604 | 0.040 |
Why?
|
Elbow Joint | 1 | 2001 | 131 | 0.040 |
Why?
|
Sex Factors | 4 | 2003 | 495 | 0.040 |
Why?
|
Chi-Square Distribution | 3 | 2007 | 145 | 0.040 |
Why?
|
Mechanics | 1 | 1998 | 4 | 0.040 |
Why?
|
Microradiography | 2 | 2005 | 4 | 0.040 |
Why?
|
Mathematics | 2 | 1990 | 31 | 0.040 |
Why?
|
Transplantation, Homologous | 3 | 1996 | 277 | 0.040 |
Why?
|
Software | 1 | 1998 | 71 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2010 | 138 | 0.040 |
Why?
|
Child | 2 | 1996 | 1344 | 0.040 |
Why?
|
Oligopeptides | 2 | 2007 | 30 | 0.040 |
Why?
|
Sialoglycoproteins | 2 | 2007 | 8 | 0.040 |
Why?
|
Craniocerebral Trauma | 1 | 2015 | 11 | 0.030 |
Why?
|
Collagen Type III | 1 | 2015 | 13 | 0.030 |
Why?
|
Collagen Type I | 1 | 2015 | 17 | 0.030 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2014 | 5 | 0.030 |
Why?
|
Receptors, Endothelin | 1 | 2014 | 5 | 0.030 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2014 | 9 | 0.030 |
Why?
|
Molybdenum | 1 | 2014 | 22 | 0.030 |
Why?
|
Hardness | 1 | 1994 | 6 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 16 | 0.030 |
Why?
|
Vasoconstriction | 1 | 2014 | 24 | 0.030 |
Why?
|
Cell Death | 1 | 2014 | 61 | 0.030 |
Why?
|
Foreign Bodies | 1 | 1995 | 25 | 0.030 |
Why?
|
Self Administration | 1 | 2014 | 36 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 130 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1994 | 38 | 0.030 |
Why?
|
Hypoxia | 1 | 2014 | 60 | 0.030 |
Why?
|
Thiophenes | 1 | 2014 | 13 | 0.030 |
Why?
|
Bone Diseases, Metabolic | 1 | 2014 | 16 | 0.030 |
Why?
|
Chromium | 1 | 2014 | 92 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2014 | 100 | 0.030 |
Why?
|
Rotation | 1 | 1994 | 142 | 0.030 |
Why?
|
Transfection | 1 | 2013 | 125 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2013 | 58 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 117 | 0.030 |
Why?
|
Physical Examination | 1 | 2014 | 117 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2006 | 118 | 0.030 |
Why?
|
Calcineurin Inhibitors | 1 | 2011 | 10 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2011 | 78 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 114 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 11 | 0.020 |
Why?
|
Transducers | 1 | 2010 | 10 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 144 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2010 | 39 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1990 | 20 | 0.020 |
Why?
|
Histological Techniques | 1 | 1990 | 6 | 0.020 |
Why?
|
Statistics as Topic | 1 | 1990 | 113 | 0.020 |
Why?
|
Blotting, Western | 1 | 2010 | 170 | 0.020 |
Why?
|
Phosphorylation | 1 | 2010 | 172 | 0.020 |
Why?
|
Absorption | 1 | 2009 | 3 | 0.020 |
Why?
|
Silicon | 1 | 2009 | 4 | 0.020 |
Why?
|
Normal Distribution | 1 | 2009 | 6 | 0.020 |
Why?
|
Rats, Long-Evans | 1 | 2009 | 13 | 0.020 |
Why?
|
Arthritis, Experimental | 1 | 2010 | 125 | 0.020 |
Why?
|
Muscle Strength | 1 | 2010 | 127 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 1990 | 324 | 0.020 |
Why?
|
Air | 1 | 1989 | 6 | 0.020 |
Why?
|
Chondrocytes | 1 | 2010 | 197 | 0.020 |
Why?
|
Water | 1 | 1989 | 34 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2009 | 108 | 0.020 |
Why?
|
Pain Management | 1 | 2010 | 143 | 0.020 |
Why?
|
Synovitis | 1 | 2008 | 22 | 0.020 |
Why?
|
Sampling Studies | 1 | 1988 | 28 | 0.020 |
Why?
|
Factor VIII | 1 | 2008 | 26 | 0.020 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2007 | 2 | 0.020 |
Why?
|
Apoptosis | 1 | 2009 | 252 | 0.020 |
Why?
|
Pain Measurement | 1 | 2010 | 462 | 0.020 |
Why?
|
Acrylates | 1 | 2007 | 2 | 0.020 |
Why?
|
Ethanol | 1 | 1989 | 137 | 0.020 |
Why?
|
Ethylene Glycol | 1 | 2007 | 3 | 0.020 |
Why?
|
Dactinomycin | 1 | 2007 | 7 | 0.020 |
Why?
|
Cycloheximide | 1 | 2007 | 10 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 7 | 0.020 |
Why?
|
Growth Differentiation Factor 5 | 1 | 2007 | 8 | 0.020 |
Why?
|
Biomimetics | 1 | 2006 | 4 | 0.020 |
Why?
|
Pain | 1 | 2010 | 391 | 0.020 |
Why?
|
Cadaver | 2 | 1998 | 359 | 0.020 |
Why?
|
Research Design | 1 | 1988 | 212 | 0.020 |
Why?
|
Cattle | 1 | 2006 | 216 | 0.020 |
Why?
|
Paleontology | 1 | 1985 | 1 | 0.020 |
Why?
|
Autoanalysis | 1 | 1985 | 3 | 0.020 |
Why?
|
Osteotomy | 1 | 2007 | 163 | 0.020 |
Why?
|
Mandibular Nerve | 1 | 2005 | 4 | 0.020 |
Why?
|
Genes, jun | 1 | 2005 | 3 | 0.020 |
Why?
|
Early Growth Response Protein 1 | 1 | 2005 | 4 | 0.020 |
Why?
|
Immediate-Early Proteins | 1 | 2005 | 6 | 0.020 |
Why?
|
Osteonectin | 1 | 2005 | 6 | 0.020 |
Why?
|
Osteopontin | 1 | 2005 | 4 | 0.020 |
Why?
|
Genes, myc | 1 | 2005 | 6 | 0.020 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 25 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2005 | 30 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2005 | 29 | 0.020 |
Why?
|
Internal Fixators | 1 | 2005 | 54 | 0.020 |
Why?
|
Muscle, Skeletal | 2 | 1998 | 349 | 0.020 |
Why?
|
Transcription Factors | 1 | 2005 | 156 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2007 | 957 | 0.020 |
Why?
|
Fetus | 1 | 1984 | 56 | 0.020 |
Why?
|
Decorin | 1 | 2003 | 15 | 0.010 |
Why?
|
Biglycan | 1 | 2003 | 15 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2003 | 50 | 0.010 |
Why?
|
Compressive Strength | 1 | 2003 | 28 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2003 | 113 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 254 | 0.010 |
Why?
|
Viscosity | 1 | 2003 | 10 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2003 | 106 | 0.010 |
Why?
|
Keratan Sulfate | 1 | 2003 | 25 | 0.010 |
Why?
|
Aggrecans | 1 | 2003 | 146 | 0.010 |
Why?
|
Injections, Intra-Articular | 1 | 2003 | 88 | 0.010 |
Why?
|
Models, Statistical | 1 | 2003 | 132 | 0.010 |
Why?
|
Anterior Cruciate Ligament | 1 | 2003 | 270 | 0.010 |
Why?
|
Swine | 1 | 2000 | 81 | 0.010 |
Why?
|
Calibration | 1 | 1998 | 22 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 1997 | 11 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1998 | 83 | 0.010 |
Why?
|
Forecasting | 1 | 1998 | 117 | 0.010 |
Why?
|
Microscopy, Polarization | 1 | 1996 | 3 | 0.010 |
Why?
|
Age Factors | 1 | 1998 | 839 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2000 | 1440 | 0.010 |
Why?
|
Autopsy | 1 | 1996 | 335 | 0.010 |
Why?
|
Fibrosis | 1 | 1995 | 43 | 0.010 |
Why?
|
Foreign-Body Migration | 1 | 1995 | 25 | 0.010 |
Why?
|
Postoperative Complications | 2 | 1993 | 957 | 0.010 |
Why?
|
Methods | 1 | 1993 | 18 | 0.010 |
Why?
|
Drug Combinations | 1 | 1993 | 82 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1992 | 70 | 0.010 |
Why?
|
Cryopreservation | 1 | 1992 | 24 | 0.010 |
Why?
|
Postoperative Period | 1 | 1993 | 288 | 0.010 |
Why?
|
Prosthesis-Related Infections | 1 | 1993 | 214 | 0.010 |
Why?
|
Retrospective Studies | 1 | 1996 | 3271 | 0.000 |
Why?
|
Metallurgy | 1 | 1986 | 2 | 0.000 |
Why?
|